Conduit Pharmaceuticals Inc. (CDT.US) reported that Farley Chele Chiavacci, acquired 37,272 shares of common stock on June 11, 2024. The transaction was coded as 'A', indicating a grant, award, or other acquisition. Following this transaction, Chiavacci's direct holdings in the company total 52,272 shares. The acquisition was executed with the shares being held directly by Chiavacci, as per the filing details. The transaction underscores a positive movement in the insider's stake in the company, which can be an indicator of the company's future prospects.

Conduit Pharmaceuticals Inc. (CDT.US) reported that Farley Chele Chiavacci, acquired 37,272 shares of common stock on June 11, 2024. The transaction was coded as 'A', indicating a grant, award, or other acquisition. Following this transaction, Chiavacci's direct holdings in the company total 52,272 shares. The acquisition was executed with the shares being held directly by Chiavacci, as per the filing details. The transaction underscores a positive movement in the insider's stake in the company, which can be an indicator of the company's future prospects.